Trial Profile
Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shock
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dopexamine
- Indications Septic shock
- Focus Therapeutic Use
- 17 Oct 2014 New trial record